Cargando…
Characteristics of Acquired Inhibitors to Factor VIII and Von Willebrand Factor Secondary to Systemic Lupus Erythematosus: Experiences From a Chinese Tertiary Medical Center
Because acquired hemophilia (AH) is a rare entity in systemic lupus erythematosus (SLE), we aimed to investigate the clinical features of SLE-related AH in Chinese patients. METHODS: This is a medical records review study carried out at a large tertiary care hospital in China from years 1986 to 2018...
Autores principales: | Cao, Xiao-Yu, Li, Meng-Tao, Zhang, Xuan, Zhao, Yan, Zeng, Xiao-Feng, Zhang, Feng-Chun, Hou, Yong, Zhu, Li-Xiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300847/ https://www.ncbi.nlm.nih.gov/pubmed/31815811 http://dx.doi.org/10.1097/RHU.0000000000001284 |
Ejemplares similares
-
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019) -
Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus
por: Taveras Alam, Sara, et al.
Publicado: (2014) -
Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975) -
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016) -
How to keep the factor VIII/von Willebrand factor complex in the circulation
por: Denis, Cécile V., et al.
Publicado: (2021)